MedPath

Premedication on Post-endodontic Pain

Phase 3
Recruiting
Conditions
Premedication
Registration Number
NCT06671743
Lead Sponsor
Gulf Medical University
Brief Summary

The goal of this clinical trial is to compare the efficacy of preoperative administration of alpha-chemo-trypsin, ibuprofen, and acetaminophen in managing post-endodontic pain in patients with symptomatic irreversible pulpitis. The main question it aims to answer is:

What is the efficacy of preoperative administration of alpha-chemo-trypsin, ibuprofen, and acetaminophen in managing post-endodontic pain in patients with symptomatic irreversible pulpitis? Participants will undergo root canal treatment after premedication. Researchers will compare \[alpha-chemo-trypsin, ibuprofen, and acetaminophen\] to see the intensity of post-endodontic pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Eligibility for root canal treatment Patients diagnosed with symptomatic irreversible pulpitis with normal apical tissue in mandibular molars
Exclusion Criteria
  • • Patient under any medication or analgesic intake for pain management.

    • Patients with any systemic health issues
    • Patient allergies to trypsin-chymotrypsin, ibuprofen, and paracetamol
    • Pregnancy.
    • Non-restorable teeth.
    • Immature roots.
    • Calcifications.
    • Resorptions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Post-endodontic pain score48 hours

Post operative pain score will be recorded using the visual analogue pain scale, where the patient will mark a point on a 10-cm line representing a continuum from 'no pain' to 'worst pain imaginable.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gulf Medical University

🇦🇪

Ajman, United Arab Emirates

© Copyright 2025. All Rights Reserved by MedPath